Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

SABSSABS
Showing 7 of 17 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in SAB BIOTHERAPEUTICS INC

NORTHERN TRUST CORP holds 362,489 shares of SABS (SAB BIOTHERAPEUTICS INC), worth $1.4M as of 2026-Q2. The position was increased (+531.2% shares). SABS represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$1.4M

Current Shares

362,489

Total Value Change

+$1.4M

Total Shares Change

+351,102

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
362,489
+531.2%
$1.4M0.0%$3.90
41
2026-Q1
Increased
57,426
+249.9%
$219,9420.0%$3.89
25
2025-Q4
Increased
16,412
+44.1%
$61,3810.0%$3.77
19
2025-Q3
Unchanged
11,387
0.0%
$22,8880.0%$1.95
0
2025-Q2
Unchanged
11,387
0.0%
$19,9840.0%$1.69
0
2025-Q1
Unchanged
11,387
0.0%
$15,4860.0%$1.48
0
2024-Q4
New
11,387
-
$43,2050.0%$4.15
31

Other major holders of SABS: ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used